EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 187 filers reported holding EVOLENT HEALTH INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $77,632,921 | +4.5% | 2,851,007 | +16.3% | 0.30% | +9.6% |
Q2 2023 | $74,269,027 | -2.5% | 2,451,123 | +4.4% | 0.27% | -10.5% |
Q1 2023 | $76,211,518 | +14.5% | 2,348,583 | -1.0% | 0.30% | +4.8% |
Q4 2022 | $66,587,761 | -21.2% | 2,371,359 | +0.8% | 0.29% | -25.3% |
Q3 2022 | $84,528,000 | +18.2% | 2,352,580 | +1.0% | 0.39% | +22.4% |
Q2 2022 | $71,522,000 | -6.4% | 2,328,935 | -1.6% | 0.32% | +18.3% |
Q1 2022 | $76,450,000 | +11.4% | 2,366,866 | -4.6% | 0.27% | +24.7% |
Q4 2021 | $68,617,000 | -13.5% | 2,479,825 | -3.1% | 0.22% | -20.4% |
Q3 2021 | $79,304,000 | +49.1% | 2,558,185 | +1.6% | 0.27% | +46.7% |
Q2 2021 | $53,199,000 | +10.1% | 2,518,889 | +5.3% | 0.18% | +1.1% |
Q1 2021 | $48,312,000 | +29.9% | 2,391,682 | +3.1% | 0.18% | +33.8% |
Q4 2020 | $37,188,000 | +30.0% | 2,319,887 | +0.7% | 0.14% | +12.4% |
Q3 2020 | $28,598,000 | +59.1% | 2,304,407 | -8.7% | 0.12% | +40.7% |
Q2 2020 | $17,979,000 | +266.4% | 2,525,156 | +179.4% | 0.09% | +177.4% |
Q1 2020 | $4,907,000 | -53.3% | 903,756 | -22.2% | 0.03% | -42.6% |
Q4 2019 | $10,514,000 | +44.9% | 1,161,728 | +15.1% | 0.05% | +28.6% |
Q3 2019 | $7,258,000 | -25.0% | 1,009,423 | -17.1% | 0.04% | -23.6% |
Q2 2019 | $9,678,000 | -44.1% | 1,217,340 | -11.6% | 0.06% | -48.1% |
Q1 2019 | $17,318,000 | -57.2% | 1,376,618 | -32.0% | 0.11% | -64.1% |
Q4 2018 | $40,416,000 | -33.5% | 2,025,886 | -5.4% | 0.30% | -20.9% |
Q3 2018 | $60,812,000 | +32.3% | 2,141,271 | -2.0% | 0.37% | +19.2% |
Q2 2018 | $45,980,000 | +30.2% | 2,184,334 | -11.9% | 0.31% | +25.2% |
Q1 2018 | $35,316,000 | -3.3% | 2,478,304 | -16.5% | 0.25% | +0.8% |
Q4 2017 | $36,509,000 | -34.7% | 2,968,244 | -5.4% | 0.25% | -40.8% |
Q3 2017 | $55,870,000 | +0.8% | 3,138,760 | +43.6% | 0.42% | +0.7% |
Q2 2017 | $55,407,000 | +69.2% | 2,185,695 | +31.5% | 0.42% | +57.6% |
Q1 2017 | $32,742,000 | +42.8% | 1,662,021 | +7.3% | 0.26% | +28.8% |
Q4 2016 | $22,923,000 | +44.5% | 1,548,823 | +140.4% | 0.20% | +46.4% |
Q3 2016 | $15,859,000 | +141.8% | 644,162 | +88.6% | 0.14% | +129.5% |
Q2 2016 | $6,558,000 | +455.3% | 341,570 | +205.5% | 0.06% | +454.5% |
Q1 2016 | $1,181,000 | – | 111,822 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FORMULA GROWTH LTD | 2,026,530 | $28,878,000 | 3.42% |
Casdin Capital, LLC | 1,110,000 | $15,818,000 | 2.78% |
Elk Creek Partners, LLC | 2,345,663 | $33,426,000 | 1.95% |
Chicago Capital, LLC | 859,914 | $12,254,000 | 1.64% |
Granahan Investment Management | 1,190,958 | $16,971,000 | 1.22% |
White Pine Investment CO | 165,020 | $2,352,000 | 1.15% |
RIVERBRIDGE PARTNERS LLC | 2,816,223 | $40,131,000 | 0.73% |
SECTORAL ASSET MANAGEMENT INC | 423,482 | $6,035,000 | 0.66% |
Trellus Management Company, LLC | 20,800 | $296,000 | 0.54% |
PEREGRINE CAPITAL MANAGEMENT LLC | 1,379,647 | $19,660,000 | 0.48% |